Therapeutic Vaccines Market by Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Therapeutic Vaccines Market by Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 71 | Pages: 177 | December 2016 | Region: Global


The Global Therapeutic Vaccines Market is estimated at $1132.5 Million in 2015, and is poised to reach $4820.26 Million by 2020 with a CAGR of 33.6%. Currently, in pipeline several approaches are being developed in order to boost the immune response to various infectious and cancerous cells.

The vaccine Market is different from any other product market. Compared to the pharmaceutical market it is relatively small, although growing at a fast rate. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years. The vaccine market is rather concentrated on both supply and demand sides. It is highly regulated and mostly dependent on public purchasers and donor policies. It has very distinct features which increase the complexity of assessing and understanding pricing and procurement in their context.

Increase in funding’s from government for vaccine development, rise in investments by the major market players, rising prevalence of disease, technological advancements, initiatives by NGO’s are some of the factors that are propelling the market growth. However, massive capital expenditures and stringent regulatory policies, high cost associated with treatment are few factors inhibiting the growth of the market.

The Global Therapeutic Vaccines Market is segmented by the type of disease into Autoimmune Disease Vaccines (Type I Diabetes), Cancer Vaccines (Multikine, PR1 Peptide Vaccine, TroVax, CYT004-MelQbG10 etc.), Neurological Disease Vaccines (ACC-001, CAD106, Parkinson’s Disease Vaccine, Alzheimer's Disease and Other Disease Vaccines), and Infectious Disease Vaccines (Hepatitis C, HIV/AIDS and Other Infectious Disease Vaccines). Furthermore, based on geography the global market is analysed under various regions namely, North America, Europe, Asia Pacific, Latin America and Middle-East & Africa. North America accounts for the large portion of revenue in the therapeutic vaccine market. The growth of this market will be boosted owing to the presence of advanced and active R&D establishments in the region.

Multinational vaccine companies historically have conducted much of the innovation, research, and development in the field of vaccine production. They have used significant revenues, global size, and deeper expertise to fund. Some of the key players influencing the global preventive vaccine market are GlaxoSmithKline, plc., Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Analysis Design                         

                2.3 Research Phases                      

                                2.3.1 Secondary Research            

                                2.3.2 Primary Research 

                                2.3.3 Econometric Modelling     

                                2.3.4 Expert Validation  

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Disease Type                       

                                5.1.1 Autoimmune Disease Vaccines      

                                5.1.2 Cancer Vaccines   

                                                5.1.2.1 Multikine

                                                5.1.2.2 PR1 Peptide

                                                5.1.2.3 TroVax

                                                5.1.2.4 CYT004-MelQbG10

                                5.1.3 Neurological Disease Vaccines        

                                                5.1.3.1 ACC- 001

                                                5.1.3.2 CAD 106

                                                5.1.3.3 Parkinson's Vaccine

                                                5.1.3.4 Alzheimer's Vaccine

                                5.1.4 Infectious Disease Vaccines             

                                                5.1.4.1 Hepatitis C Vaccines

                                                5.1.4.2 HIV/AIDS Vaccines

                                                5.1.4.3 Other Infectious Disease Vaccines

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Argentina

                                6.4.4 Mexico     

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle East            

                                6.5.3 Africa        

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 GlaxoSMithKline plc.                              

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Merck and Company                              

                8.3 Bavarian Nordic                        

                8.4 CSL Limited                 

                8.5 Emergent Biosolutions Inc.                  

                8.6 Novartis AG                

                8.7 Johnson and Johnson                             

                8.8 MedImmune LLC                     

                8.9 Pfizer Inc.                    

                8.10 Sanofi Pasteur                        

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Therapeutic Vaccines Market By Region, From 2015-2020 ( USD Million )
  2. Global Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  3. Global Autoimmune Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  4. Global Cancer Vaccines Market By Region, From 2015-2020 ( USD Million )
  5. Global Neurological Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  6. Global Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  7. Global Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  8. Global Multikine Market By Region, From 2015-2020 ( USD Million )
  9. Global PR1 Peptide Market By Region, From 2015-2020 ( USD Million )
  10. Global TroVax Market By Region, From 2015-2020 ( USD Million )
  11. Global CYT004-MelQbG10 Market By Region, From 2015-2020 ( USD Million )
  12. Global Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  13. Global ACC- 001 Market By Region, From 2015-2020 ( USD Million )
  14. Global CAD 106 Market By Region, From 2015-2020 ( USD Million )
  15. Global Parkinson's Vaccine Market By Region, From 2015-2020 ( USD Million )
  16. Global Alzheimer's Vaccine Market By Region, From 2015-2020 ( USD Million )
  17. Global Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  18. Global Hepatitis C Vaccines Market By Region, From 2015-2020 ( USD Million )
  19. Global HIV/AIDS Vaccines Market By Region, From 2015-2020 ( USD Million )
  20. Global Other Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  21. North America Therapeutic Vaccines Market By Region, From 2015-2020 ( USD Million )
  22. North America Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  23. North America Autoimmune Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  24. North America Cancer Vaccines Market By Region, From 2015-2020 ( USD Million )
  25. North America Neurological Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  26. North America Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  27. North America Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  28. North America Multikine Market By Region, From 2015-2020 ( USD Million )
  29. North America PR1 Peptide Market By Region, From 2015-2020 ( USD Million )
  30. North America TroVax Market By Region, From 2015-2020 ( USD Million )
  31. North America CYT004-MelQbG10 Market By Region, From 2015-2020 ( USD Million )
  32. North America Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  33. North America ACC- 001 Market By Region, From 2015-2020 ( USD Million )
  34. North America CAD 106 Market By Region, From 2015-2020 ( USD Million )
  35. North America Parkinson's Vaccine Market By Region, From 2015-2020 ( USD Million )
  36. North America Alzheimer's Vaccine Market By Region, From 2015-2020 ( USD Million )
  37. North America Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  38. North America Hepatitis C Vaccines Market By Region, From 2015-2020 ( USD Million )
  39. North America HIV/AIDS Vaccines Market By Region, From 2015-2020 ( USD Million )
  40. North America Other Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  41. United States Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  42. Canada Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  43. United States Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  44. Canada Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  45. United States Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  46. Canada Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  47. United States Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  48. Canada Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  49. Europe Therapeutic Vaccines Market By Region, From 2015-2020 ( USD Million )
  50. Europe Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  51. Europe Autoimmune Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  52. Europe Cancer Vaccines Market By Region, From 2015-2020 ( USD Million )
  53. Europe Neurological Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  54. Europe Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  55. Europe Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  56. Europe Multikine Market By Region, From 2015-2020 ( USD Million )
  57. Europe PR1 Peptide Market By Region, From 2015-2020 ( USD Million )
  58. Europe TroVax Market By Region, From 2015-2020 ( USD Million )
  59. Europe CYT004-MelQbG10 Market By Region, From 2015-2020 ( USD Million )
  60. Europe Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  61. Europe ACC- 001 Market By Region, From 2015-2020 ( USD Million )
  62. Europe CAD 106 Market By Region, From 2015-2020 ( USD Million )
  63. Europe Parkinson's Vaccine Market By Region, From 2015-2020 ( USD Million )
  64. Europe Alzheimer's Vaccine Market By Region, From 2015-2020 ( USD Million )
  65. Europe Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  66. Europe Hepatitis C Vaccines Market By Region, From 2015-2020 ( USD Million )
  67. Europe HIV/AIDS Vaccines Market By Region, From 2015-2020 ( USD Million )
  68. Europe Other Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  69. U.K. Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  70. Germany Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  71. France Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  72. Italy Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  73. Spain Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  74. U.K. Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  75. Germany Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  76. France Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  77. Italy Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  78. Spain Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  79. U.K. Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  80. Germany Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  81. France Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  82. Italy Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  83. Spain Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  84. U.K. Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  85. Germany Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  86. France Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  87. Italy Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  88. Spain Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  89. Asia-Pacific Therapeutic Vaccines Market By Region, From 2015-2020 ( USD Million )
  90. Asia-Pacific Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  91. Asia-Pacific Autoimmune Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  92. Asia-Pacific Cancer Vaccines Market By Region, From 2015-2020 ( USD Million )
  93. Asia-Pacific Neurological Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  94. Asia-Pacific Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  95. Asia-Pacific Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  96. Asia-Pacific Multikine Market By Region, From 2015-2020 ( USD Million )
  97. Asia-Pacific PR1 Peptide Market By Region, From 2015-2020 ( USD Million )
  98. Asia-Pacific TroVax Market By Region, From 2015-2020 ( USD Million )
  99. Asia-Pacific CYT004-MelQbG10 Market By Region, From 2015-2020 ( USD Million )
  100. Asia-Pacific Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  101. Asia-Pacific ACC- 001 Market By Region, From 2015-2020 ( USD Million )
  102. Asia-Pacific CAD 106 Market By Region, From 2015-2020 ( USD Million )
  103. Asia-Pacific Parkinson's Vaccine Market By Region, From 2015-2020 ( USD Million )
  104. Asia-Pacific Alzheimer's Vaccine Market By Region, From 2015-2020 ( USD Million )
  105. Asia-Pacific Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  106. Asia-Pacific Hepatitis C Vaccines Market By Region, From 2015-2020 ( USD Million )
  107. Asia-Pacific HIV/AIDS Vaccines Market By Region, From 2015-2020 ( USD Million )
  108. Asia-Pacific Other Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  109. China Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  110. India Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  111. Japan Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  112. South Korea Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  113. China Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  114. India Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  115. Japan Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  116. South Korea Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  117. China Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  118. India Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  119. Japan Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  120. South Korea Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  121. China Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  122. India Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  123. Japan Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  124. South Korea Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  125. Latin America Therapeutic Vaccines Market By Region, From 2015-2020 ( USD Million )
  126. Latin America Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  127. Latin America Autoimmune Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  128. Latin America Cancer Vaccines Market By Region, From 2015-2020 ( USD Million )
  129. Latin America Neurological Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  130. Latin America Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  131. Latin America Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  132. Latin America Multikine Market By Region, From 2015-2020 ( USD Million )
  133. Latin America PR1 Peptide Market By Region, From 2015-2020 ( USD Million )
  134. Latin America TroVax Market By Region, From 2015-2020 ( USD Million )
  135. Latin America CYT004-MelQbG10 Market By Region, From 2015-2020 ( USD Million )
  136. Latin America Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  137. Latin America ACC- 001 Market By Region, From 2015-2020 ( USD Million )
  138. Latin America CAD 106 Market By Region, From 2015-2020 ( USD Million )
  139. Latin America Parkinson's Vaccine Market By Region, From 2015-2020 ( USD Million )
  140. Latin America Alzheimer's Vaccine Market By Region, From 2015-2020 ( USD Million )
  141. Latin America Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  142. Latin America Hepatitis C Vaccines Market By Region, From 2015-2020 ( USD Million )
  143. Latin America HIV/AIDS Vaccines Market By Region, From 2015-2020 ( USD Million )
  144. Latin America Other Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  145. Brazil Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  146. Argentina Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  147. Mexico Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  148. Brazil Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  149. Argentina Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  150. Mexico Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  151. Brazil Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  152. Argentina Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  153. Mexico Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  154. Brazil Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  155. Argentina Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  156. Mexico Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  157. Middle East & Africa Therapeutic Vaccines Market By Region, From 2015-2020 ( USD Million )
  158. Middle East & Africa Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  159. Middle East & Africa Autoimmune Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  160. Middle East & Africa Cancer Vaccines Market By Region, From 2015-2020 ( USD Million )
  161. Middle East & Africa Neurological Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  162. Middle East & Africa Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  163. Middle East & Africa Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  164. Middle East & Africa Multikine Market By Region, From 2015-2020 ( USD Million )
  165. Middle East & Africa PR1 Peptide Market By Region, From 2015-2020 ( USD Million )
  166. Middle East & Africa TroVax Market By Region, From 2015-2020 ( USD Million )
  167. Middle East & Africa CYT004-MelQbG10 Market By Region, From 2015-2020 ( USD Million )
  168. Middle East & Africa Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  169. Middle East & Africa ACC- 001 Market By Region, From 2015-2020 ( USD Million )
  170. Middle East & Africa CAD 106 Market By Region, From 2015-2020 ( USD Million )
  171. Middle East & Africa Parkinson's Vaccine Market By Region, From 2015-2020 ( USD Million )
  172. Middle East & Africa Alzheimer's Vaccine Market By Region, From 2015-2020 ( USD Million )
  173. Middle East & Africa Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  174. Middle East & Africa Hepatitis C Vaccines Market By Region, From 2015-2020 ( USD Million )
  175. Middle East & Africa HIV/AIDS Vaccines Market By Region, From 2015-2020 ( USD Million )
  176. Middle East & Africa Other Infectious Disease Vaccines Market By Region, From 2015-2020 ( USD Million )
  177. Middle East Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  178. Africa Therapeutic Vaccines Market By Disease Type, From 2015-2020 ( USD Million )
  179. Middle East Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  180. Africa Cancer Vaccines Market By Type, From 2015-2020 ( USD Million )
  181. Middle East Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  182. Africa Neurological Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  183. Middle East Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
  184. Africa Infectious Disease Vaccines Market By Type, From 2015-2020 ( USD Million )
North America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Middle East And Africa High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application...
Latin America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Europe High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glau...
Asia Pacific High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology...
High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glaucoma, H...
North America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Middle East And Africa Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pestici...
Latin America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Europe Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...
Asia Pacific Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screeni...
Global Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.